Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Article activity feed
-
-
SciScore for 10.1101/2020.04.17.046185: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources All the generated 3D all atom models were energetically minimized by using the Yasara Minimization server (35) 2.3 Antibody 3D modeling and mutagenesis: Starting from the 3D atomic coordinates of the crystallized neutralizing antibodies m396 (2dd8.pdb(44)) and S230 (6nb7.pdb, (45)) directed against the SARS-CoV-1 spike RBD domain, we modelled the interactions of m396 and S230 (6nb7.pdb, (45)) with SARS-CoV-2 spike RBD domain, by superimposing the fragment antigen based (FAB) portions of m396 (2dd8.pdb (44)) and S230 (6nb7.pdb, (45) (both complexed with SARS-CoV-1 RBD) with the SARS-CoV-2 spike RBD … SciScore for 10.1101/2020.04.17.046185: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
NIH rigor criteria are not applicable to paper type.Table 2: Resources
Antibodies Sentences Resources All the generated 3D all atom models were energetically minimized by using the Yasara Minimization server (35) 2.3 Antibody 3D modeling and mutagenesis: Starting from the 3D atomic coordinates of the crystallized neutralizing antibodies m396 (2dd8.pdb(44)) and S230 (6nb7.pdb, (45)) directed against the SARS-CoV-1 spike RBD domain, we modelled the interactions of m396 and S230 (6nb7.pdb, (45)) with SARS-CoV-2 spike RBD domain, by superimposing the fragment antigen based (FAB) portions of m396 (2dd8.pdb (44)) and S230 (6nb7.pdb, (45) (both complexed with SARS-CoV-1 RBD) with the SARS-CoV-2 spike RBD domain, complexed with ACE2 (6vw1.pdb), by using PyMOL. ACE2suggested: NoneSoftware and Algorithms Sentences Resources The sequences of the retrieved 48 crystallized structures (with reference to those crystallized structures indicated with “Certain” or “High” confidence level in pGenThreader output) were aligned by using ClustalW (31) implemented in the Jalview package (32). ClustalWsuggested: (ClustalW, RRID:SCR_017277)Jalviewsuggested: (Jalview, RRID:SCR_006459)All the generated 3D all atom models were energetically minimized by using the Yasara Minimization server (35). 2.2. 3D atomic models preparation of SARS-CoV-2 Spike protein in post-fusion conformation and SARS-CoV-2 Spike-ACE2 interactions in pre-fusion conformations: The 3D comparative model of SARS-CoV-2 spike trimer in post-fusion conformation was built by multi-template modeling by using Modeller (36). Modellersuggested: (MODELLER, RRID:SCR_008395)The obtained final models were examined in VMD, PyMOL, and SPDBV according to our protocols (30, 49). PyMOLsuggested: (PyMOL, RRID:SCR_000305)The way the FoldX AnalyseComplex operates is by unfolding the selected targets and determining the stability of the remaining molecules and then subtracting the sum of the individual energies from the global energy. FoldXsuggested: (FoldX, RRID:SCR_008522)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on pages 33 and 7. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-